Q-linea, a biotech company based in Uppsala, Sweden, develops fully automated solutions for healthcare providers enabling the ... m to accurately diagnose sepsis in the shortest possible time. By providing optimal information for every individual patient, the antibiotic burden may be lowered. The ASTar™ system will deliver rapid antibiotic susceptibility results within 6 hours directly from positive blood cultures. Our development platform, ASTrID®, will deliver both molecular identification in a panel of 50+ pathogens including resistance markers, and a phenotypic antibiotic susceptibility profile in 10 hours from blood draw. Both systems will report bacterial growth or inhibition as Minimum Inhibitory Concentration values. read more